Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Debt to Equity: 2016-2018

Historic Debt to Equity for Anaptysbio (ANAB) over the last 2 years, with Dec 2018 value amounting to $0.00.

  • Anaptysbio's Debt to Equity fell 94.77% to $0.00 in Q4 2018 from the same period last year, while for Dec 2018 it was $0.00, marking a year-over-year decrease of 94.77%. This contributed to the annual value of $0.00 for FY2018, which is 94.77% down from last year.
  • As of Q4 2018, Anaptysbio's Debt to Equity stood at $0.00, which was down 73.35% from $0.00 recorded in Q3 2018.
  • Over the past 5 years, Anaptysbio's Debt to Equity peaked at $0.12 during Q1 2017, and registered a low of -$0.36 during Q4 2016.
  • In the last 3 years, Anaptysbio's Debt to Equity had a median value of $0.02 in 2018 and averaged $0.00.
  • As far as peak fluctuations go, Anaptysbio's Debt to Equity skyrocketed by 106.80% in 2017, and later tumbled by 94.77% in 2018.
  • Quarterly analysis of 3 years shows Anaptysbio's Debt to Equity stood at -$0.36 in 2016, then spiked by 106.80% to $0.02 in 2017, then tumbled by 94.77% to $0.00 in 2018.
  • Its Debt to Equity stands at $0.00 for Q4 2018, versus $0.00 for Q3 2018 and $0.01 for Q2 2018.